Cats, although naturally resilient and agile, often suffer from chronic diseases that require comprehensive treatment. Sanford Biotech develops modern biological therapies based on mesenchymal stem cells (MSCs) and platelet-rich plasma (PRP), which support natural tissue regeneration processes and reduce the need for long-term drug therapy.